Why China's expanding pharma market is still a risky bet

July 21, 2012 | BY

clpstaff &clp articles

China's pharmaceutical market is expanding rapidly, but recent policy developments mean multinationals need to rethink their strategy

Share:

Statistics from CITI predict China will have a $200 billion pharmaceutical market by 2020, making it the second largest in the world. “This begs the question can multinationals afford not to expand considering how fast the market is growing compared to the global market?” said Christoph Hezel, a lawyer specialising in healthcare at Taylor Wessing in Beijing.

This expected growth should translate into exciting growth opportunities for healthcare multinationals. But policy developments and government pressure to increase healthcare access while controlling costs are taking a toll.